Agoracom Blog Home

Archive for the ‘TransCanna Holdings Inc.’ Category

TransCanna’s $TCAN.ca Lyfted Farms Set to Increase Cultivation by 300% $VFF.ca $ACB.ca $GTII.ca $TEQ.ca

Posted by Jesse Champagne at 9:51 AM on Tuesday, March 2nd, 2021
tcan-square

  • Company anticipates escalation in cultivation to have direct effect on revenue growth
  • Strategic location of the Company’s new facility takes full advantage of California’s lowest industrial electrical costs
  • “Our new facility gives us a massive competitive cost advantage that will increase our margins and empower us to offer consumers the best products at the most competitive prices,” said Bob Blink

Vancouver, British Columbia–(Newsfile Corp. – March 2, 2021) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (OTC: TCNAF) (“TransCanna” or the “Company”) has increased its cultivation capacity by 300%, enabling it to effectively triple production of its most profitable and in-demand product: exotic indoor flower. With this increased cultivation capacity, Lyfted Farms – hailed in the industry for its premium genetics and seasoned team of master cultivators – can now meet consumer-driven demand in Northern California while expanding into the sizable Southern California home containing over 23,000,000 residents.

“We literally cannot keep up with demand as the vast majority of shipments are selling out within days of landing on retail shelves,” said Alan Applonie, General Manager for TransCanna subsidiary, Lyfted Farms. “We have been waiting for the right time to enter the Southern California market but needed this increase in cultivation capacity to effectively build and preserve our reputation for unwavering quality and reliability with our retailers and consumers,” said Mr. Applonie.

In addition to increasing output, the strategic location of the Company’s new Daly facility in Modesto, California, takes full advantage of California’s lowest industrial electrical costs per kilowatt-hour.

“Electricity is the largest direct cost for indoor cultivation so the location of our new facility gives us a massive competitive cost advantage that will increase our margins and empower us to offer consumers the best products at the most competitive prices,” said Bob Blink, CEO of TransCanna.

The additional cultivation rooms coming online within the Daly facility also unlock Lyfted Farms’ ability to leverage its multi-decade relationships within the industry. The expansion in cultivation capacity opens the door for collaboration with other dominant California cannabis lifestyle brands. Ensuing co-branding efforts (soon to be revealed) will be powerful and will impact all meaningful cannabis market segments within the state.

The new developments represent significant strides in TransCanna’s mission to establish itself as California’s leading cannabis conglomerate.

Read more: https://agoracom.com/ir/TranscannaHoldings/forums/discussion/topics/756376-transcanna-s-lyfted-farms-set-to-increase-cultivation-by-300/messages/2306057#message

California Grants #Cannabis Cultivation License to TransCanna $TCAN.ca $VFF.ca $ACB.ca $GTII.ca $TEQ.ca

Posted by AGORACOM-JC at 3:24 PM on Saturday, February 20th, 2021
tcan-square

Game-changing achievement for the budding cannabis enterprise

  • Received a highly coveted cultivation license from the State of California that will accelerate the Company’s cultivation capacity almost immediately
  • license represents a major milestone achievement in its endeavors to be California’s leading fully integrated cannabis cultivator, processor, manufacturer, wholesaler and distributor
  • “Obtaining this license is a significant turning point for TransCanna and opens up the door to the explosive growth we’ve been positioning ourselves for,” said Bob Blink

Vancouver, British Columbia–(February 20, 2021) –  TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has received a highly coveted cultivation license from the State of California that will accelerate the Company’s cultivation capacity almost immediately.

The State of California has granted a cultivation license to Lyfted Farms – a TransCanna wholly owned subsidiary – for its flagship Daly facility in Modesto, California. Bob Blink, TransCanna CEO states “Such cultivation licenses in the region are notoriously difficult to obtain. Current applications are back-logged and not even being considered for processing by the county until the end of 2021.”

For TransCanna, the license represents a major milestone achievement in its endeavors to be California’s leading fully integrated cannabis cultivator, processor, manufacturer, wholesaler and distributor.

“Obtaining this license is a significant turning point for TransCanna and opens up the door to the explosive growth we’ve been positioning ourselves for,” said Bob Blink. “Demand has been consistently outstripping supply for our exotic indoor cannabis strains, and now with this new massive facility receiving approval for cultivation, we can finally meet that demand and continue to scale. This will make us one of the largest licensed facilities of its kind in the State of California.”

In addition to cultivation, the new Daly facility empowers TransCanna to increase its scope of offerings and establish its dominance in the California cannabis supply chain.

The Daly facility will anchor other TransCanna operations and serve as a supply chain hub for third party farms across Northern California, offering secure storage, concentrate manufacturing, wholesale market-making, white label services, and State-wide distribution.

Prior to achieving its cultivation license, the facility gained its distribution license in June 2020. Next, TransCanna is eagerly anticipating its processing license (pending approval by the State of California mid to late March) which will qualify the company to dry, cure, trim, grade, and package cannabis onsite. In addition to saving time and money for in-house brands with on-site processing, the processing license will enable TransCanna to open up new revenue streams servicing third party growers.

“California’s cannabis market is $5 billion in sales and growing, and we are well on our way to establishing ourselves at the epicenter of this category with our cultivation, processing, wholesaling and distribution arms of the entire California supply chain,” said Bob Blink, TransCanna CEO.

About TransCanna

TransCanna Holdings Inc. is a California-based, Canadian-listed company building cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

TransCanna’s wholly owned subsidiary Lyfted Farms is California’s authentic cannabis brand whose pioneering spirit has been continuously providing the finest cannabis flower genetics and cultivation methods since 1984. The Lyfted Farms brand of exclusive cannabis flower is sold at premium retailers throughout the state. With its new cultivation facility in Daly, California, the company is now poised to become one of the largest and most efficient vertically integrated cannabis companies in the California market.

Read more: https://agoracom.com/ir/TranscannaHoldings/forums/discussion/topics/755740-california-grants-cannabis-cultivation-license-to-transcanna/messages/2304595#message

TransCanna $TCAN.ca Final Stage of Phase One Completion at Daly Facility $VFF.ca $ACB.ca $GTII.ca $TEQ.ca

Posted by AGORACOM-JC at 8:12 AM on Wednesday, February 17th, 2021
tcan-square
  • Phase One expected to generate up to CAD$ 28,000,000 to $32,000,000 additional annual Revenues
  • Company anticipates the remaining construction to take 60 days from the date of execution of the Definitive Agreements with Wild Horse Properties L.P., which will provide the company access to a $2,000,000 convertible construction loan.

Vancouver, British Columbia — (February 17, 2021) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company“) is extremely excited to announce the Company has entered into the final stage of the Phase One build-out of its Daly Facility located in Modesto, CA. With the facility construction approximately 80% complete, the Company anticipates the remaining construction to take 60 days from the date of execution of the Definitive Agreements with Wild Horse Properties L.P., which will provide the company access to a $2,000,000 convertible construction loan.

“The entire team is thrilled to complete the remainder of the Phase One Daly Facility build-out. The opportunity ahead of us to scale our genetic offerings, cultivation, state-wide distribution and processing divisions is very exciting. Each of these functions have synergistic impacts on the efficiencies of the business. Top-tier manufacturing for concentrates will soon follow, significantly leveraging up the entire portfolio,” stated Alan Applonie, General Manager of the Daly Facility.

Once construction is complete, on or around April 15, 2021, the company will boast the following cultivation, distribution, and processing capabilities at its flagship Daly Facility:

Cultivation

  • Five (5) 4,500 sq. ft. grow rooms
  • Each new cultivation room is expected to add an additional $12-$14M CAD
  • The incremental gain of 500 lights represents a 330% increase over current capacity
  • Each room will be outfitted with a minimum of 100 lights.
  • The first completed cultivation room planned to have plants under lights by March 15, 2021

Distribution

  • Robust distribution infrastructure with secured loading and unloading of vans
  • Climate controlled storage facilities that can accommodate 100 acres of harvested product, cured bulk product, and more than 100 pallet positions for finished goods
  • Aggregation of the company’s crop management products
  • Finished goods from multiple brands and partners for efficient logistics between the Northern and Southern California markets
  • Revenue is expected to commence in March and to achieve an annualized run rate of $8-10M CAD

Processing

  • Curing, grading, and packaging of cannabis flower from compliant 3rd party farms
  • Provides the operational basis to execute a comprehensive white-label/co-packaging and brand creation center to fill lower price point market segments
  • Revenue is expected to begin in March and to achieve an annualized run rate of $8-10M CAD
  • State Processing License expected by March 15th, 2021

Read More: https://agoracom.com/ir/TranscannaHoldings/forums/discussion/topics/755487-final-stage-of-phase-one-completion-at-daly-facility/messages/2303991#message

TransCanna TCAN.ca Announces Binding Term Sheet for US$2 Million Secured Convertible Loan $VFF.ca $ACB.ca $CGC.ca $GTII.ca $TEQ.ca

Posted by AGORACOM-JC at 2:10 PM on Wednesday, February 3rd, 2021
tcan-square
  • Proceeds of the Convertible Loan are to be used exclusively for capital expenditures at the Company’s Daly Facility located in Modesto, California
  • Loan to Increase Production Capacity by 400% & Shift Company into a Cashflow Positive Status Once Daly Facility Opened

Vancouver, British Columbia–(February 3, 2021) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company“) is pleased to announce that it has entered into a binding term sheet (the “Term Sheet“) with Wild Horse Properties L.P. (the “Lender” or “Wild Horse“) for a secured convertible loan (the “Convertible Loan“) in the aggregate principal amount of US$2 million (the “Principal Amount.“).

The proceeds of the Convertible Loan are to be used exclusively for capital expenditures at the Company’s Daly Facility located in Modesto, California (the “Facility.“).

“We are excited to finally unlock the production capacity of the Daly Facility with this direct investment. We believe that scaling our cultivation capacity precipitates industrial level distribution, manufacturing and processing rewarding shareholders with significant revenue growth. We have been in the planning stage for several months,” stated Alan Applonie, Company General Manager, “and are very happy to have secured the necessary funding required to realize this vision.” A reminder to shareholders, Mr. Applonie comes from Taylor Farms an organic produce grower in the central valley where Alan was part of the original founding management team and responsible for annual gross revenues exceeding US$1 Billion.

The Facility build out consists of four phases; with receipt of the Company’s occupancy permit for Phase One, the Company will be shifting its distribution business from the Jerusalem property. Cultivation will continue at full capacity at the Jerusalem facility.

Read More: https://agoracom.com/ir/TranscannaHoldings/forums/discussion/topics/754587-transcanna-announces-binding-term-sheet-for-us-2-million-secured-convertible-loan/messages/2301895#message

TransCanna $TCAN.ca Subsidiary Exceeds 30% THC In Independent Test $VFF.ca $ACB.ca $CGC.ca $GTII.ca $TEQ.ca

Posted by AGORACOM-JC at 7:35 AM on Thursday, January 7th, 2021
tcan-square
  • Announces record THC test results achieved via data driven process improvements at wholly owned subsidiary Lyfted Farms.
  • Recent testing by a State certified, third party laboratory confirmed total THC to be 31.3% and total cannabinoids at 41.43% for the Lyfted Farms’ Garlic NoodlesTM cannabis flower, both are record levels for Lyfted Farms indoor cultivation team.
  • Notably, total flower yield also increased by 17%.

Vancouver, British Columbia–(January 7, 2021) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) announces record THC test results achieved via data driven process improvements at wholly owned subsidiary Lyfted Farms.

Recent testing by a State certified, third party laboratory confirmed total THC to be 31.3% and total cannabinoids at 41.43% for the Lyfted Farms’ Garlic NoodlesTM cannabis flower, both are record levels for Lyfted Farms indoor cultivation team. Notably, total flower yield also increased by 17%.

Systematic, data driven process enhancements to multiple facets of the genetics-to-harvest cycle have resulted in superior test results for total THC, total cannabinoids, and yield metrics.

Read More: https://agoracom.com/ir/TranscannaHoldings/forums/discussion/topics/752519-transcanna-subsidiary-exceeds-30-thc-in-independent-test/messages/2296437#message

TransCanna $TCAN.ca Expansion to Lead to Massive Cannabis Production Increase $VFF.ca $ACB.ca $CGC.ca $GTII.ca $TEQ.ca

Posted by AGORACOM-JC at 8:27 AM on Monday, December 14th, 2020
tcan-square

A 400% increase in cultivation and production capacity is expected as they expand into their new facility

“This facility is going to resonate through the industry, not only in California, but I believe worldwide,” says CEO, Bob Blink.

TransCanna Holdings seeks to contribute to the cannabis industry as a strategic vertically integrated acquisition company. TransCanna is currently transforming. They’re now scaling the company to leverage their vertically integrated cannabis facility in Modesto California. In fact, it will be one of the largest cannabis facilities in the State. It will also have access to over 39 million residents and 240 million visitors per year. Further, the facitlity will be over 20 times larger than their current site.

“We’re really excited about phase one financing because it’s going to enable us to realize a four hundred percent increase in cultivation and production capacity,” says General Manager, Alan Applonie.

All of TransCanna’s product in its original site is sold out until March of 2021. So, bringing this additional capacity online will allow the company to deliver the product to consumers.

“With Phase One expansion plans nearly complete, TransCanna is prepared to seize on some massive opportunities,” says Blink.

In addition, the company recently acquired two California companies, a high-end edible producer Soldaze and a premium indoor cultivator and distributer Lyfted Farms. Combining one of the largest cannabis production facilities with the brands and management teams from these acquisitions will make TransCanna a major opportunity for investors and partners alike.

Source: https://www.b-tv.com/transcanna-holdings-expansion-cannabis-production-company-feature-ep-353/

7 Small Cap #Cannabis Companies That Will Benefit From Increased #Marijuana Legalization In The United States $AVCN.ca $HBOR.ca $HOLL.ca $INNO.ca $SPDR.ca $TBI.ca $TCAN.ca

Posted by AGORACOM-JC at 11:10 AM on Monday, November 23rd, 2020
Square Scarf USA Flag On Cannabis Marijuana Leaf Silk Like Lightweight  Scarfs Hair Neck Wraps for Women 99 × 99cm: Amazon.co.uk: Clothing

Despite the collapse of marijuana and cannabis related stocks in the last 18 months, there is no denying that Cannabis related products are going to go through a paradigm shifting, parabolic growth stage around the world over this decade for the following reasons: 

1.     Cannabis legalization is gaining momentum around the world. 

2.     Momentum is primarily driven by the realization that cannabis may have a range of medicinal, therapeutic and wellness applications. 

3.     It is the most widely cultivated, consumed and trafficked drug worldwide (United Nations Office on Drugs and Crime). 

So what is this going to translate into? 

The global cannabis market size was valued at $US 10.6 Billion in 2018 and is projected to reach $97.5 Billion by the end of 2026, a CAGR of 32.92% (Fortune Business Insights

WHY WILL THIS TIME BE DIFFERENT? 

Big promises, big IR budgets, big hype …. Big Letdown. 

That pretty much sums up the last cycle of Cannabis related companies that focused on speed, stories and stock prices rather than the one simple but important thing they should have been doing – building a real business. 

Investors will remember that the same thing happened during the dot-com era.  As with the cannabis collapse over the last 18 months, what followed back in 2000 was a long period of mourning in which many investors had sworn off tech stocks, just as they have with cannabis stocks today. 

But it wasn’t long until tech investors dusted themselves off and realized tech was here to stay – but this time they were only going to focus on real companies with real businesses.  What we got was Amazon, Google, Linkedin, Facebook and then the rest was history. 

US LEGALIZATION IS ACCELERATING 

After postponing a proposed September vote, the full U.S. House of Representatives is expected to vote in December on a bill that would effectively legalize marijuana federally by removing it from the Controlled Substances Act. 

According to Politico, the House Democratic leadership is preparing for a vote on the Marijuana Opportunity Reinvestment and Expungement (MORE) Act of 2019. In addition to legalizing marijuana federally, the legislation would allow states to continue to choose how to regulate a commercial MJ industry. 

Democrats in close elections balked at voting on the MORE Act in September amid concerns that voters might question the importance of legalizing marijuana when Congress had failed to agree on a coronavirus aid package. 

But in the November election, five more states legalized medical and/or recreational marijuana, and a recent poll shows cannabis legalization is more popular than ever. 

Big cap marijuana stocks have already seen significant gains 

Meet the 8 new small cap marijuana horsemen of the next leadership group that are firing on all cylinders (in alphabetical order).  

Avicanna (AVCN :TSX) (AVCN : OTCQX) ( 0NN: FSE) is a vertically-integrated biopharmaceutical company developing and commercializing various cannabinoid-based products for the global marketplace.

When we say vertically integrated, we mean it. Avicanna has 4 fully operating divisions to address the entire market for Cannabis products as follows:

1.  The company has a full line of high end CBD based skin care products serving the consumer retail segment with Canadian distribution through Medical Cannabis by Shoppers, as well as global distribution later this year.  These are the only known CBD cosmetics backed by clinical trials. 

2.  Avicanna’s superior medical cannabis line also features products distributed through Medical Cannabis by Shoppers, the online arm of Canada’s largest drugstore chain. In addition, the company recently received certification and authorization for the sale of pharmaceutical cannabinoid products with medical prescriptions in Colombia.  

3.  Avicanna also hosts a full pipeline of Pharmaceuticals in various stages of trials to address Dermatology, Psychiatry, Neurology, Pain and Oncology. Three of the company’s products are already as far as phase 2.  

AND… if that is not enough …  

4.  Avicanna’s Colombian cultivation division hosts 500,000 Sq ft of low cost and USDA certified organic Cannabis Cultivation. The company recently Made History As The First Ever Export Of Feminized Hemp Seeds From Colombia To The United States. 7,000,000 Seeds For $380,000, with an additional 75,000,000 Seeds Available For Export In Several Pending Transactions. 

For more information about the company, please check out the Avicanna HUB on AGORACOM.  

Harborside (HBOR: CSE), (HSDEF: OTCQX) has generated over $400,000,000 (NOT a typo) since its inception in 2006.  We thought that would get your attention.

What Do They Do?

HBOR is a California-focused, vertically integrated, fully licensed cannabis company with its business consisting of three primary segments:

1. Retail Dispensaries

2. Wholesale

3. Cultivation and Processing

HIGHLIGHTS

  • Founded in 2006. One of the oldest and most respected cannabis retailers in California
  • Awarded one of the first six medical cannabis licenses in the USA
  • Operations have generated over $400M in cumulative sales since inception
  • Retail operations command 3% of California’s entire retail market

Q3 REVENUE ($USD)

  • ·        $19.6M +43%  vs. Q3 2019

9 MONTHS ENDED SEPT. 30, 2020

  • ·        $50.4M + 33% vs 2019

OTHER Q3 HIGHLIGHTS

  • 21.2% Sequential Revenue Growth, with Record Gross Revenues and Continued Positive Adjusted EBITDA of $4.5 million
  • Strong Combined Gross Margin of 54.7% (1) Driven by Improved Harvest Yields and Higher Wholesale Volumes
  • Expects Full Year Gross Revenues of Approximately $61 Million – $63 Million with Adjusted EBITDA of 8-10%

For more information about the company, please check out the Harborside Inc  hub on AGORACOM.

Hollister Biosciences Inc. (HOLL:CSE) (HSTRF:OTC) (HOB: FRANKFURT) is a multi-state cannabis company with products in 230 dispensaries throughout California and over 80 dispensaries throughout Arizona, translating into the following great success:

REVENUES  $USD

  • Q1 +317%  YoY to $862,000
  • Q2 +3685% YoY to  $8,500,000
  • Q3 +5081% YoY to $12,500,000

TOTAL Q1/Q2/Q3

  • REVENUE             $21.8M

With the recent passage of Proposition 207 – legalizing the cultivation, sale and consumption of recreational cannabis in the state of Arizona Hollister is extremely well positioned to capitalize. This can best be summed up by quote of Venom Extracts Founder below:

“Seeing recreational Cannabis legalized in the state is an encouraging sign and is hopefully another step toward federal legalization. It should lead to increased tax revenue and job creation. The recreational cannabis market in Arizona could be valued at up to US $760 million by 2024 1 , significantly expanding the total addressable market for Cannabis in the state. We look forward to making our product line available to both the medical and recreational end user.” Shared Jacob Cohen , Founder of Venom Extracts, Hollister’s 100% owned subsidiary based in Arizona

On September 23rd, 2020, Venom achieved the first revenue milestone by generating in excess of CDN$30,000,000 of revenue calculated from January 1 st , 2020

In addition to organic sales, Hollister has several high-level partnerships that demonstrate how trusted the Company is within the industry, including:

For more information about the company, please check out the Hollister Biosciences Inc. hub on AGORACOM.

Innocan Pharma Corporation (INNO: CSE) (IP4:FSE) is developing the pharmaceutical guided missile to defeat coronavirus lung infections. The company specializes in the development of new drug platforms which combine unique properties of Cannabinoids.

3 Fully Operating Divisions For Investor Diversification

Innocan has 3 fully operating divisions to address the market for Cannabis products.  As a Cannabis investor, why limit yourself to a Company with just one specialty, when Innocan offers you exposure to both the exploding world of cannabis pharma, as well as, a portfolio of patent-pending and launch ready consumer health products.

  1.  PHARMACEUTICAL – THE GUIDED MISSILE – Revolutionary technology targeting lungs infected with coronavirus or other viral infections.
  2. CONSUMER RETAIL – DERMA COSMETICS – A premium derma cosmetics brand, manufacturing has commenced with distribution agreements in place.
  3. OVER THE COUNTER (OTC) PRODUCTS FOR PAIN RELIEF – patent-pending CBD pain relief brand received FDA technical validation.

Global Manufacturing / Distribution Agreements

  • Endless Sky Inc. a Canadian large scale Cannabis extractor (Manufacturing and Distribution – Canada)
  • Swiss CBD provider Cloud 9 Switzerland LLC (Distribution – Italy and Switzerland)
  • Active Therapeutics Ltd of Lancashire, United Kingdom (Distribution – UK and Ireland markets)

Superior Management Team

In the small cap world, the jockey(s) that drive the horse are just as important as the horse itself.  The InnoCan Leadership Group Is Incomparable In The Small Cap World, Comprised Of Leading Israeli Pharmaceutical Executives including:

  • Executive Chairman (Ron Mayron) was the CEO Of Teva Israel, one of the largest generic pharmaceutical companies in the world
  • Co-Founder & VP Business Development (Yoram Drucker) was the Founder of 2 NASDAQ Companies (Pluristem & Brainstorm)
  • Chief Technology Officer (Nir Avram) is a former member of the pharma innovation team at Perrigo, producer of OTC consumer goods and specialty pharma.
  • Chief Executive Officer (Iris Bincovich) has a proven track record in opening global markets, having managed hundreds of successful transactions in OTC, cosmetics and dermatology.

Together they have built one of the most formidable teams in the small cap cannabis world

For more information about the company, please check out the Innocan Pharma Corporation hub on AGORACOM.

Spyder Cannabis Inc. (SPDR :TSXV) is a Cannabis, Vape and CBD retailer with three retail business units.

  1. SALE OF CANNABIS PRODUCTS – The Company has TWO cannabis dispensaries currently in operation. The first being a location in Calgary, Alberta and the second in Niagara Falls. Both dispensaries are located in busy commercial hubs. The management team is currently evaluating several additional locations in both Alberta and Ontario where it intends to expand the Spyder Cannabis brand’s footprint.
  2. SALE OF HEMP CBD (US) Company is also pursuing the sale of Hemp based CBD products from locations in the USA.
  3. SMOKING CESSATION PRODUCTS IN ONTARIO The company sells electronic cigarettes, E-juice and accessories for the “vape” business from five Canadian retail locations; Woodbridge, Scarborough, Pickering, Niagara Falls and Burlington, Ontario. Spyder has established itself as a savvy retailer.

For more information about the company, please check out the Spyder Cannabis  hub on AGORACOM.

Thoughtful Brands, Inc. (TBI: CSE)( 1WZ1: FWB)( PEMTF: OTCQB) is a global natural health products and eCommerce technology company that is operating at full throttle. 

  • Acquired eCommerce retailers with combined total sales of approximately $29,000,000 with an EBITDA of approximately 12.5%.
  • Current customer base of over 200,000 customers with additional leads of over 600,000 potential new customers
  • Enhanced eCommernce solution through Unified Funding’s software which facilitated over $350 million in consumer transactions (CAD $93.8 million) in 2019 from more than one million paying customers.
  •  Low-cost production will be vertically integrated into retail brands to achieve up to 20x margin increase.

We’ll let these revenue numbers speak for themselves.

  • August 2020 CAD $3,809,000
  • July 2020 CAD $2,340,000
  • June 2020 CAD $2,712,000

The above represents an increase of 19%, over the same period in 2019.

QUARTERLY REVENUE $CAD

  • Q1 $7,600,000 Growth
  • Q2  $12,800,000 Growth 

TOTAL Q1 AND Q2

  • REVENUE  $20,400,000
  •  GROSS PROFIT  $2,154,357

The company has its sights set on European expansion through a joint venture with Franchise Cannabis Corp. The company will now sell and market Franchise-manufactured CBD, hemp and cosmetic products in the European Union, Switzerland, Norway and the UK, utilizing its eCommerce platform.

The company also completed acquisition of Verrian, which owns and operates a 110,000-square foot pharmaceutical manufacturing facility in Radebuel, Germany. This acquisition will assist the company in tapping into the burgeoning market for psychedelics as Verrian specializes in developing psychedelic derived medicines for treatments for addictions, including opioids and alcohol.

In Addition, the company entered into a definitive agreement to acquire American CBD Extraction Corp. and its Kentucky-based wholly owned subsidiary East Kentucky Extractions, LLC. the Company will gain access to an abundance of hemp biomass in Kentucky, and own a fully equipped and licensed 41,000 square foot facility that can process more than 1,200 pounds of hemp per day.

For more information about the company, please check out the Thoughtful Brands hub on AGORACOM. 

TransCanna (TCAN:CSE) (TH8:FSE) owns a 196,000 square foot cannabis Facility, the largest known fully licensed cannabis facility in California.

  • CAD $24.9M  Revenue Run Rate from 10,000 sq.ft  test facility
  • CAD $90M Annual Revenue expected from first full year of production at Fully Licensed Daly Street Facility.
  • Acquired two California companies,
  • High-end award winning edible producer Soldaze
    • Premium indoor cultivator and distributer Lyfted Farms
  • Lyfted Farms products sold in select Cookies Locations – The most recognizable name in high-end Cannabis.
  • 2019 California Cannabis sales over $3B, industry currently fragmented 
  • Direct to dispensary model, cutting out the middleman

 REVENUES  $CAD

  • Q1  $906,000
  • Q2  $4,300,000

 TOTAL Q1 AND Q2

  • REVENUE     $5,206,000    
  • GROSS MARGIN $1,920,000

OFF-TAKE AGREEMENTS

·       The Company has secured multiple off-take agreements in anticipation of late Q1 production coming out of the Daly facility

REVENUE GUIDENCE

  • ·         Company’s internal gross revenue target for the 2020 fiscal year ranges from CAD$12,000,000 up to CAD$14,000,000 (with anticipated net profits from sales of $600,000 up to $700,000)
    On track to achieve this benchmark
  •            Company maintains its guidance for a gross revenue target of CAD$55,000,000 to CAD$75,000,000 (with anticipated net profits from sales of $6,600,000 up to $9,000,000) for the fiscal year 2021.
  •            This revenue guidance is only for phase one of four in the Daly facility

·          For more information about the company, please check out the TransCanna hub on AGORACOM.

Thanks for reading and discovering these great small cap cannabis companies.  Please be sure to visit the AGORACOM Small Cap Cannabis Gateway often to stay up to date with new companies at:

https://agoracom.com/portal/Small-Cap-Marijuana-Cannabis-Stocks

TransCanna $TCAN.ca Closes 1st Tranche of Unit Financing $VFF.ca $ACB.ca $CGC.ca $GTII.ca $TEQ.ca

Posted by AGORACOM-JC at 7:30 PM on Wednesday, November 18th, 2020
tcan-square
  • Announced that it has closed the 1st tranche of a Unit financing. In connection with the closing, the Company issued 1,838,000 Units at a price of $0.55 per Unit, for gross proceeds of $1,010,900.
  • Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance.

Vancouver, British Columbia–(November 18, 2020) –  TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company“) is pleased to announce that it has closed the 1st tranche of a Unit financing. In connection with the closing, the Company issued 1,838,000 Units at a price of $0.55 per Unit, for gross proceeds of $1,010,900. Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE or such other stock exchange the Company’s shares may be trading on is equal to or greater than $1.25 for a period of 20 consecutive trading days. 63,040 Broker’s warrants were issued in connection with finder’s fees payable and in lieu of 8% cash finder’s fees, 63,040 Broker’s Units were issued.

The private placement is subject to the approval of the Canadian Securities Exchange (“CSE”) and the securities will be subject to a four-month hold period under securities laws. The Company intends to use the net proceeds from the private placement for working capital purposes.

The Company did not file a material change report more than 21 days before the expected closing of the private placement as the details of the private placement and the participation therein by related parties of the company were not settled until shortly prior to closing and the company wished to close on an expedited basis for sound business reasons and in a time frame consistent with usual market practices for transactions of this nature.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed company building Cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at [email protected].

On behalf of the Board of Directors
Bob Blink, CEO
604-349-3011

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

TransCanna $TCAN.ca Appoints Jennifer Brown as Director $VFF.ca $ACB.ca $CGC.ca $GTII.ca $TEQ.ca

Posted by AGORACOM-JC at 7:42 AM on Monday, November 16th, 2020
tcan-square
  • Announced the appointment of Ms. Jennifer Brown to the Company’s Board of Directors

Vancouver, British Columbia–(November 16, 2020) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company“) is pleased to announce the appointment of Ms. Jennifer Brown to the Company’s Board of Directors.

Ms. Brown is an Experienced Enterprise Risk Manager, Anti-Money Laundering, Compliance & Fraud Prevention Professional. Ms. Brown has over 15 years managing various organizations’ operations divisions and enterprise risk management programs at various financial institutions. In her roles, Ms. Brown has been responsible for the development and implementation of analytic fiscal reports, policies, and procedures that satisfy compliance requirements and maintaining thorough understanding of state and federal laws and regulations to ensure compliance. Mr. Brown earned a Bachelors’ Degree in Criminal Justice with concentration on Homeland Security from Brandman University and is currently pursuing an MBA in Accounting from National University. Ms. Brown is a member of the Association of Certified Anti-Money Laundering Specialist (ACAMS), California Financial Crimes Investigators Association (CFCIA), Northern California Compliance Roundtable, Sacramento Metro EDGE, and Sacramento Young Professionals (YP).

Ms. Brown has also been appointed a member of the Company’s audit committee.

“We are excited to have Jennifer join the Board of Directors here at Transcanna. She is a great addition to our team and brings a wealth of experience and knowledge to help propel the Company forward,” stated Bob Blink, the Company’s CEO.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed company building Cannabis-focused brands for the California lifestyle through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at [email protected].

On behalf of the Board of Directors
Bob Blink, CEO
604-349-3011

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

TransCanna $TCAN.ca Announces Five Year Deal with Fresca LLC $VFF.ca $ACB.ca $CGC.ca $GTII.ca $TEQ.ca

Posted by AGORACOM-JC at 7:26 AM on Thursday, November 12th, 2020
tcan-square
  • Lyfted Farms has entered into a 5-year agreement with Fresca LLC to promote and co-brand premium indoor cannabis flower
  • The resulting new retail SKU’s have surpassed several prior sales velocity records for Lyfted Farms
  • Sales velocity has long been a key indicator for demand and viable results demonstrating the products are well positioned

Vancouver, British Columbia–(November 12, 2020) – TransCanna Holdings Inc. (CSE: TCAN) (GSE: TH8) (“TransCanna” or the “Company”) announces the collaboration of Lyfted Farms with Fresca LLC; breaks sales velocity records.

Lyfted Farms has entered into a 5-year agreement with Fresca LLC to promote and co-brand premium indoor cannabis flower. The resulting new retail SKU’s have surpassed several prior sales velocity records for Lyfted Farms. Sales velocity has long been a key indicator for demand and viable results demonstrating the products are well positioned.

This collaboration highlights the marketplace power of California’s most authentic indoor cultivator combined with the Fresca Brand and distribution channels into the world-famous Cookie’s, Lemonade, and Dr. Greenthumb stores.

Bob Blink, founder of Lyfted Farms and CEO of TransCanna, shares that, “The opportunity to bring Lyfted Farms reputation for consistently high quality indoor cannabis flower into the Fresca Brand and the Cookie’s retail distribution system is exciting and will enable us to showcase the production capacity of the Daly Facility.”

Gilbert Milam Jr., aka “Berner” @berner415, Founder and CEO of Cookie’s, notes “The owners of Fresca helped innovate Bay Area culture when I was growing up through music…when they mentioned to me about starting a cannabis brand…I recommended that they find a quality indoor cultivator and I think Lyfted Farms is the perfect partner for them. We look forward to carrying their brand onto our shelves and watching their Statewide expansion.”

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed, Company building cannabis-focused brands for the California lifestyle through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at [email protected].

On behalf of the Board of Directors
Bob Blink, CEO
604-349-3011

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs regarding future events of management of the Company. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. This information and these statements referred to herein as “forward-looking statements”, are not historical facts, are made as of the date of this news release and include without limitation estimates and forecasts and statements as to management’s expectations for growth and the commencement of operations of the Company’s Daly facility.

The forward-looking information in this press release is based upon certain assumptions that management considers reasonable in the circumstances, including that operations will commence at the Company’s Daly facility in Modesto, California, as and when expected.

These forward-looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially from any future results, events or developments expressed or implied by such forward-looking statements. Risks and uncertainties associated with the forward-looking information in this news release include, among others, dependence on obtaining and maintaining regulatory approvals, including state, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits to complete upgrades to its Daly facility in a timely manner; engaging in activities which currently are illegal under U.S. federal law and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, particularly in California, due to inconsistent public opinion, perception of the medical-use and adult-use marijuana industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth;; reliance on management; and the effect of capital market conditions and other factors (including those related to the COVID-19 pandemic) on capital availability; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers.

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look, except in accordance with applicable securities laws.